NASDAQ:CBPO
Delisted
China Biologic Products Stock News
$119.99
+0 (+0%)
At Close: May 27, 2022
China Biologic Shares Soar on Go-Private Takeover Bid
10:22am, Thursday, 19'th Sep 2019
The offer is for $120 a share, a 16% premium to Wednesday's closing stock price for the biopharmaceutical company.
UPDATE 1-China Biologic receives offer to be taken private at $120 a share
03:19am, Thursday, 19'th Sep 2019China Biologic receives $4.59 bln take-private buyout offer
09:36pm, Wednesday, 18'th Sep 2019China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
08:01pm, Wednesday, 18'th Sep 2019
BEIJING, Sept. 18, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in C
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
12:00am, Monday, 09'th Sep 2019The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug
12:00am, Thursday, 05'th Sep 2019The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books
12:00am, Wednesday, 04'th Sep 20195 Guru Stocks With Predictable Businesses
09:31pm, Thursday, 29'th Aug 2019
Thor Industries makes the list Continue reading...
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2019 Results - Earnings Call Transcript
12:00am, Thursday, 08'th Aug 2019China Biologic Products Inc (CBPO) Q2 2019 Earnings Call Transcript
03:23am, Wednesday, 07'th Aug 2019
CBPO earnings call for the period ending June 30, 2019.
China Biologic Products Holdings, Inc. 2019 Q2 - Results - Earnings Call Slides
12:00am, Wednesday, 07'th Aug 2019China Biologic Products Holdings, Inc. to Host Earnings Call
09:30am, Tuesday, 06'th Aug 2019
NEW YORK, NY / ACCESSWIRE / August 6, 2019 / China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August
